HIV Infection Clinical Trial
Official title:
TransPrEP: Social Network-Based PrEP Adherence for Transgender Women in Peru
The investigators propose a social network-based PrEP adherence intervention as part of a comprehensive, context-specific approach to HIV prevention for TW in Lima, Peru. In order to be effective, PrEP-based prevention strategies need to address not only biological efficacy, but also individual behavioral decision-making processes, interpersonal partnership contexts of risk, peer norms of sexual behavior and PrEP adherence, and structural access to prevention technologies. Using a health promotion behavioral model that combines Social Action Theory with social network theories of information dissemination and collective behavior change, the investigators propose to develop and refine a network-based intervention that promotes PrEP adherence in the existing social networks of TW. Formative research will outline individual, partner-level, and network-based contexts of sexual risk behavior, patterns of social network interactions, anticipated adoption and use of new prevention technologies, and optimal content for a PrEP adherence intervention. Findings will be used to define the elements of a prevention intervention using social networks of TW and social media technologies to generate, implement, and reinforce social norms of PrEP adherence and risk behavior reduction for TW.
Pre-Exposure Prophylaxis (PrEP) has biological efficacy in reducing risk for HIV acquisition
but its clinical effectiveness is strongly influenced by patient adherence, which is in turn
influenced by social and behavioral factors. Trials conducted among serodiscordant
heterosexual African couples who were engaged in supportive romantic partnerships found PrEP
to be highly effective for HIV prevention. In contrast, studies with socially marginalized
populations in Latin America without strong interpersonal support networks, such as
transgender women (TW), found substantially lower levels of adherence and, as a result,
effectiveness. We believe that new, social network-based strategies to promote PrEP
adherence, coupled with behavioral interventions to minimize risk compensation, will be
critical to controlling the spread of HIV among TW in Latin America.
TW in Peru are at high risk for HIV infection (30-33% HIV prevalence) and in urgent need of
new approaches to prevention that adequately address HIV risk as part of their life contexts.
Due to their social and economic marginalization and lack of support from traditional
neighborhood and family networks, TW frequently neglect traditional approaches to HIV/STI
prevention that have been developed for men who have sex with men (MSM), and report high
rates of compensated sex, unprotected intercourse, and sexually transmitted infection (STI)
co-infections. Despite their socially marginalized status, communities of TW in Lima are
frequently connected through dense social and geographic networks that provide support
outside of traditional community systems, disseminate new information and ideas, and define
and maintain standards of behavior. While these social networks provide a critical framework
for the dissemination and maintenance of TW community norms, they have not previously been
used as a framework for HIV prevention.
We propose a social network-based PrEP adherence intervention as part of a comprehensive,
context-specific approach to HIV prevention for TW in Lima, Peru. In order to be effective,
PrEP-based prevention strategies need to address not only biological efficacy, but also
individual behavioral decision-making processes, interpersonal partnership contexts of risk,
peer norms of sexual behavior and PrEP adherence, and structural access to prevention
technologies. Using a health promotion behavioral model that combines Social Action Theory
with social network theories of information dissemination and collective behavior change, we
propose to develop and refine a network-based intervention that promotes PrEP adherence in
the existing social networks of TW. Formative research will outline individual,
partner-level, and network-based contexts of sexual risk behavior, patterns of social network
interactions, anticipated adoption and use of new prevention technologies, and optimal
content for a PrEP adherence intervention. Findings will be used to define the elements of a
prevention intervention using social networks of TW and social media technologies to
generate, implement, and reinforce social norms of PrEP adherence and risk behavior reduction
for TW.
Aim 1. To conduct an open evaluation of a social network-based PrEP adherence intervention
for TW in Peru. The intervention will be piloted with a group of 10-15 TW recruited from a
social network within a single geographic area. Using a dynamic process of implementation,
refinement, and re-implementation over a 6-month period, we will assess acceptability and
feasibility of specific intervention and evaluation components. Data will be used to finalize
the study design, intervention manual, and quantitative assessment tools for the pilot
randomized controlled trial.
Aim 2. To conduct a pilot RCT of a social network-based PrEP adherence intervention for TW in
Peru. The investigators plan to enroll 6 social network clusters of TW (3 clusters per arm,
recruited from 2 seeds matched from 3 geographical areas in Lima, Peru) (total N=90 TW
enrolled [15 TW per cluster] to achieve at least N=60 TW completers [10 TW per cluster]) that
will be randomized to participate in either the network-based PrEP adherence intervention or
a control intervention. The primary outcome will be adherence to PrEP (measured via
laboratory analysis of presence of detectable drug in serum, laboratory analysis of presence
of detectable drug in hair, and participant self-report). The major secondary outcome will be
behavioral risk compensation, specifically the degree to which participants in the two arms
do or do not modify HIV risk behaviors while taking PrEP. Behavioral and biological
assessments will be conducted at Baseline, 3-month, and 6-month intervals.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02135419 -
Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions
|
Phase 3 | |
Active, not recruiting |
NCT02663856 -
My Smart Age With HIV: Smartphone Self-assessment of Frailty
|
||
Completed |
NCT02663869 -
Aging With HIV at Younger vs Older Age: a Diverse Population With Distinct Comorbidity Profiles
|
||
Completed |
NCT02659306 -
Metformin Immunotherapy in HIV Infection
|
Phase 1 | |
Completed |
NCT02846402 -
Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda
|
N/A | |
Terminated |
NCT02743598 -
Liraglutide for HIV-associated Neurocognitive Disorder
|
Phase 4 | |
Completed |
NCT02921516 -
Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings
|
N/A | |
Completed |
NCT02564341 -
Targeting Effective Analgesia in Clinics for HIV - Intervention
|
N/A | |
Active, not recruiting |
NCT02302950 -
A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas
|
N/A | |
Completed |
NCT01852942 -
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
|
Phase 2 | |
Completed |
NCT02269605 -
Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment
|
Phase 1 | |
Completed |
NCT01830595 -
Lactoferrin Treatment in HIV Patients
|
Phase 2 | |
Terminated |
NCT01902186 -
Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir
|
Phase 4 | |
Terminated |
NCT02109224 -
Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection
|
Phase 1 | |
Completed |
NCT02525146 -
Birmingham Access to Care Study
|
N/A | |
Completed |
NCT02118168 -
Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002
|
N/A | |
Completed |
NCT01946217 -
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
|
N/A | |
Completed |
NCT02527135 -
Text Messaging to Improve HIV Testing Among Young Women in Kenya
|
N/A | |
Active, not recruiting |
NCT02602418 -
Neural Correlates of Working Memory Training for HIV Patients
|
N/A | |
Completed |
NCT01805427 -
Antiretroviral Therapy and Extreme Weight
|
N/A |